Results 251 to 260 of about 28,560,894 (288)
Some of the next articles are maybe not open access.
Glucagon-Like Peptide 2 (GLP-2), An Intestinotrophic Mediator
Current Protein & Peptide Science, 2004Glucagon-like peptide 2 (GLP-2) is a newly discovered gastrointestinal peptide with 33% sequence homology to glucagon. GLP-2 has attracted interest because of its potent intestinotrophic endocrine/paracrine actions. The peptide, consisting of 33-amino-acid, results from expression of the glucagon gene in the enteroendocrine L-cells of the intestinal ...
openaire +2 more sources
Glucagon-like peptides 1 and 2
Current Opinion in Supportive & Palliative Care, 2015Chemotherapy often causes adverse effects, including pain, bloating, diarrhea, and inflammation and ulceration of the mucous membranes lining the digestive tract, which are collectively referred to as mucositis. Unfortunately, no remedy has been found yet to manage these side-effects.The intestinal glucagon-like peptide-2 (GLP-2) is secreted from the ...
openaire +3 more sources
Glucagon-like peptide-1, a new hormone of the entero-insular axis
Diabetologia, 1992C Ørskov, C Örskov
exaly
Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson’s disease
Expert Opinion on Investigational Drugs, 2020Elliot J Glotfelty +2 more
exaly
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
Gastroenterology, 2011Aleksey V Matveyenko +2 more
exaly